Attention to the standardized combined therapy of adenocarcinoma of the esophagogastric junction

JI Jia-fu,JI Xin
2012-01-01
Abstract:The incidence of adenocarcinoma of the esophagogastric junction(AEG) is dramatically increasing in Western countries,while it is not increasing in Eastern countries.Two surgical phase III trials have indicated that AEG type I should be treated surgically as esophageal cancer,and right thoracic approach with a mediastinal lymph node dissection may be recommended.While types II and III should be regarded as true gastric cancer,and a transhiatal extended gastrectomy is the preferable approach for type II and type III tumors.Meanwhile,perioperative chemotherapy and chemoradiotherapy have been approved in the clinical trials recently.
What problem does this paper attempt to address?